ELOXX PHARMACEUTICALS, INC. Shares of Common Stock ($0.01 par value per share) SALES AGREEMENTSales Agreement • May 24th, 2023 • Eloxx Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 24th, 2023 Company Industry JurisdictionEloxx Pharmaceuticals, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc. (the “Agent”), as follows: